{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:45:21Z","timestamp":1788929121668,"version":"build-2803163510"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","surgonc.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.soc.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T14:51:49Z","timestamp":1711032709000},"page":"467-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Advances in Diagnostic, Staging, and Restaging Evaluation of Esophageal and Gastric Cancer"],"prefix":"10.1016","volume":"33","author":[{"given":"Tamar","family":"Nobel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Sihag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.soc.2024.02.002_bib1","first-page":"71","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.soc.2024.02.002_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.soc.2024.02.002_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.soc.2024.02.002_bib6","doi-asserted-by":"crossref","DOI":"10.2217\/fon-2022-0093","article-title":"Matterhorn: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric\/gastroesophageal junction cancer","volume":"18","author":"Janjigian","year":"2022","journal-title":"Future Oncol"},{"key":"10.1016\/j.soc.2024.02.002_bib7","doi-asserted-by":"crossref","first-page":"10184","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.soc.2024.02.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2015.06.062","article-title":"Pretreatment Dysphagia in Esophageal Cancer Patients May Eliminate the Need for Staging by Endoscopic Ultrasonography","volume":"101","author":"Ripley","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.soc.2024.02.002_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00464-016-5187-0","article-title":"Endoscopic dilation of benign esophageal anastomotic strictures over 16\u00a0mm has a longer lasting effect","volume":"31","author":"van Halsema","year":"2017","journal-title":"Surg Endosc"},{"issue":"4","key":"10.1016\/j.soc.2024.02.002_bib10","doi-asserted-by":"crossref","DOI":"10.1308\/003588414X13946184900282","article-title":"A\u00a0comparative study of the iron status of patients with oesophageal adenocarcinoma to determine suitability for a clinical trial of iron chelation therapy","volume":"96","author":"Ford","year":"2014","journal-title":"Ann R Coll Surg Engl"},{"issue":"39","key":"10.1016\/j.soc.2024.02.002_bib11","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v26.i39.6037","article-title":"Metastatic pattern in esophageal and gastric cancer: Influenced by site and histology","volume":"26","author":"Verstegen","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"32","key":"10.1016\/j.soc.2024.02.002_bib12","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10740","article-title":"Metastatic spread in patients with gastric cancer","volume":"7","author":"Riihim\u00e4ki","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.soc.2024.02.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2009.10.013","article-title":"Barrett\u2019s Surveillance Identifies Patients with Early Esophageal Adenocarcinoma","volume":"123","author":"Wong","year":"2010","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib14","doi-asserted-by":"crossref","DOI":"10.21037\/acs.2017.03.14","article-title":"8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: Application to clinical practice","volume":"6","author":"Rice","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"issue":"7","key":"10.1016\/j.soc.2024.02.002_bib15","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1245\/s10434-018-6447-0","article-title":"Is the 8th Edition of the AJCC TNM Staging System Sufficiently Reasonable for All Patients with Noncardia Gastric Cancer? A 12,549-Patient International Database Study","volume":"25","author":"Lu","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2024.02.002_bib16","article-title":"Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Ajani","year":"2023","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.soc.2024.02.002_bib17","author":"Shaili Aggarwal"},{"issue":"1","key":"10.1016\/j.soc.2024.02.002_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.athoracsur.2013.02.069","article-title":"The Society of Thoracic Surgeons Guidelines on the Diagnosis and Staging of Patients With Esophageal Cancer","volume":"96","author":"Varghese","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.soc.2024.02.002_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s11605-018-3710-4","article-title":"Quality of Endoscopy Reports for Esophageal Cancer Patients: Where Do We Stand?","volume":"22","author":"Barbetta","year":"2018","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol29020048","article-title":"Endoscopic Diagnosis and Treatment of Superficial Esophageal Squamous Cell Cancer: Present Status and Future Perspectives","volume":"29","author":"Ishihara","year":"2022","journal-title":"Curr Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10388-016-0527-7","article-title":"Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society","volume":"14","author":"Oyama","year":"2017","journal-title":"Esophagus"},{"issue":"7","key":"10.1016\/j.soc.2024.02.002_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jso.26844","article-title":"Advances in screening and detection of gastric cancer","volume":"125","author":"Xia","year":"2022","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/0016-5085(82)90009-9","article-title":"Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma","volume":"82","author":"Graham","year":"1982","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.soc.2024.02.002_bib24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1097\/JTO.0000000000000222","article-title":"Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET\/CT have a role?","volume":"9","author":"Betancourt Cuellar","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.soc.2024.02.002_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcts.2007.01.037","article-title":"Is FDG-PET indicated for superficial esophageal cancer?","volume":"31","author":"Little","year":"2007","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"6","key":"10.1016\/j.soc.2024.02.002_bib26","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00464-009-0783-x","article-title":"Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer","volume":"24","author":"Choi","year":"2010","journal-title":"Surg Endosc"},{"issue":"6","key":"10.1016\/j.soc.2024.02.002_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11307-005-0017-0","article-title":"Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer","volume":"7","author":"Lowe","year":"2005","journal-title":"Mol Imaging Biol"},{"issue":"10","key":"10.1016\/j.soc.2024.02.002_bib28","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1440-1746.2009.05927.x","article-title":"Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography","volume":"24","author":"Takizawa","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"Suppl 12","key":"10.1016\/j.soc.2024.02.002_bib29","doi-asserted-by":"crossref","first-page":"S1602","DOI":"10.21037\/jtd.2019.06.50","article-title":"Accuracy of endoscopic ultrasound in esophageal cancer staging","volume":"11","author":"Krill","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"issue":"46","key":"10.1016\/j.soc.2024.02.002_bib30","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v23.i46.8193","article-title":"Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?","volume":"23","author":"Luu","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.soc.2024.02.002_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cgh.2010.08.020","article-title":"Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus","volume":"8","author":"Young","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.soc.2024.02.002_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158373","article-title":"Endoscopic ultrasound for preoperative esophageal squamous cell carcinoma: A meta-analysis","volume":"11","author":"Luo","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.soc.2024.02.002_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2010.10.046","article-title":"Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases","volume":"73","author":"Pouw","year":"2011","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib34","doi-asserted-by":"crossref","DOI":"10.1148\/rg.292085106","article-title":"Multimodality assessment of esophageal cancer: Preoperative staging and monitoring of response to therapy","volume":"29","author":"Kim","year":"2009","journal-title":"Radiographics"},{"issue":"18","key":"10.1016\/j.soc.2024.02.002_bib35","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2004.01.083","article-title":"Systematic review of the staging performance of 18F- fluorodeoxyglucose positron emission tomography in esophageal cancer","volume":"22","author":"Van Westreenen","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2024.02.002_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1067\/mge.2001.112741","article-title":"Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma","volume":"53","author":"Vazquez-Sequeiros","year":"2001","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.soc.2024.02.002_bib37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.gie.2008.08.016","article-title":"Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer","volume":"69","author":"Keswani","year":"2009","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.soc.2024.02.002_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/dc.20796","article-title":"Evaluation of performance of EUS-FNA in preoperative lymph node staging of cancers of esophagus, lung, and pancreas","volume":"36","author":"Peng","year":"2008","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.soc.2024.02.002_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2019.04.032","article-title":"Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma","volume":"229","author":"Nobel","year":"2019","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2010.07.013","article-title":"FDG-PET\/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy","volume":"80","author":"De Iaco","year":"2011","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.soc.2024.02.002_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-017-1176-6","article-title":"Endoscopic ultrasonography compared with multidetector computed tomography for the preoperative staging of gastric cancer: a meta-analysis","volume":"15","author":"Nie","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.02.002_bib42","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-008-0959-y","article-title":"Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: Results of a multicentre prospective study","volume":"36","author":"Chatterton","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.soc.2024.02.002_bib43","article-title":"Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer","volume":"44","author":"Yoshioka","year":"2003","journal-title":"J\u00a0Nucl Med"},{"issue":"22","key":"10.1016\/j.soc.2024.02.002_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.27550","article-title":"A\u00a0prospective evaluation of the utility of 2-deoxy-2-[18F] fluoro- D -glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer","volume":"118","author":"Smyth","year":"2012","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.soc.2024.02.002_bib45","first-page":"156","article-title":"18F-Fludeoxyglucose-Positron Emission Tomography\/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC)","author":"Gertsen","year":"2021","journal-title":"JAMA Surg"},{"issue":"10","key":"10.1016\/j.soc.2024.02.002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.02.002_bib47","article-title":"Brain metastases from stomach cancer - The role of different treatment modalities and efficacy of palliative radiotherapy","volume":"20","author":"Kraszkiewicz","year":"2015","journal-title":"Rep Practical Oncol Radiother"},{"issue":"19","key":"10.1016\/j.soc.2024.02.002_bib48","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v17.i19.2407","article-title":"Incidence of brain metastasis in patients with esophageal carcinoma","volume":"17","author":"Smith","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.soc.2024.02.002_bib49","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannov\u00e1","year":"2022","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.soc.2024.02.002_bib50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1245\/s10434-019-08077-1","article-title":"Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma","volume":"27","author":"Groh","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib51","first-page":"189","article-title":"Staging Laparoscopy in Gastric Cancer. Accuracy and Impact on Therapy","volume":"18","author":"Muntean","year":"2009","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib52","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejso.2021.08.003","article-title":"Staging laparoscopy in patients with advanced gastric cancer: A single center cohort study","volume":"48","author":"Borgstein","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2024.02.002_bib53","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ejso.2007.01.007","article-title":"The role of staging laparoscopy in oesophagogastric cancers","volume":"33","author":"de Graaf","year":"2007","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.02.002_bib54","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/j.gastro.2009.05.001","article-title":"Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location","volume":"137","author":"Murphy","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.soc.2024.02.002_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-022-00416-x","article-title":"HER2-targeted advanced metastatic gastric\/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives","volume":"10","author":"Li","year":"2022","journal-title":"Biomark Res"},{"issue":"4","key":"10.1016\/j.soc.2024.02.002_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/PAI.0000000000000423","article-title":"HER2 Status in Gastric and Gastroesophageal Junction Cancer: Results of the Large, Multinational HER-EAGLE Study","volume":"26","author":"Kim","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"9742","key":"10.1016\/j.soc.2024.02.002_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"37","key":"10.1016\/j.soc.2024.02.002_bib58","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1200\/EDBK_175231","article-title":"Immunotherapy for Esophageal and Gastric Cancer","author":"Kelly","year":"2017","journal-title":"American Society of Clinical Oncology Educational Book"},{"issue":"7","key":"10.1016\/j.soc.2024.02.002_bib59","first-page":"2636","article-title":"Updated Immunotherapy for Gastric Cancer","volume":"12","author":"Narita","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"13","key":"10.1016\/j.soc.2024.02.002_bib60","doi-asserted-by":"crossref","first-page":"E33377","DOI":"10.1097\/MD.0000000000033377","article-title":"Immune checkpoint inhibitors are effective in the treatment of Epstein-Barr virus-associated gastric cancer: A case report","volume":"102","author":"An","year":"2023","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.soc.2024.02.002_bib61","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000005501","article-title":"Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study","volume":"277","author":"Vos","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2024.02.002_bib62","article-title":"Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II\/III DANTE\/IKF-s633 Trial","author":"Lorenzen","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.soc.2024.02.002_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112839","article-title":"Tremelimumab and durvalumab combination for the non-operative management (Nom) of microsatellite instability (MSI)-high resectable gastric or gastroesophageal junction cancer: The multicentre, single-arm, multi-cohort, phase ii infinity study","volume":"13","author":"Raimondi","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.soc.2024.02.002_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(23)00243-1","article-title":"Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial","volume":"8","author":"Reynolds","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"15_suppl","key":"10.1016\/j.soc.2024.02.002_bib65","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.4004","article-title":"Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452)","volume":"39","author":"Reynolds","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.02.002_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/j.1442-2050.2004.00355.x","article-title":"Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen","volume":"17","author":"Yang","year":"2004","journal-title":"Dis Esophagus"},{"issue":"8","key":"10.1016\/j.soc.2024.02.002_bib67","article-title":"Factors associated with false-negative endoscopic biopsy results after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma","volume":"94","author":"Chao","year":"2015","journal-title":"Medicine (United States)"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib68","doi-asserted-by":"crossref","DOI":"10.1007\/s00464-011-1911-y","article-title":"The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer","volume":"26","author":"Misra","year":"2012","journal-title":"Surg Endosc"},{"issue":"8","key":"10.1016\/j.soc.2024.02.002_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/dote.12274","article-title":"Staging accuracy of endoscopic ultrasound for esophageal cancer after neoadjuvant chemotherapy: A meta-analysis and systematic review","volume":"28","author":"Sun","year":"2015","journal-title":"Dis Esophagus"},{"issue":"11","key":"10.1016\/j.soc.2024.02.002_bib70","article-title":"Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer","volume":"112","author":"Sook","year":"2008","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.soc.2024.02.002_bib71","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma","volume":"73","author":"Mandard","year":"1994","journal-title":"Clinicopathologic correlations. Cancer"},{"issue":"3","key":"10.1016\/j.soc.2024.02.002_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000258","article-title":"Correlation between Standardized Uptake Value in Preneoadjuvant and Postneoadjuvant Chemoradiotherapy and Tumor Regression Grade in Patients with Locally Advanced Esophageal Cancer","volume":"41","author":"Baksh","year":"2018","journal-title":"American Journal of Clinical Oncology: Cancer Clin Trials"},{"key":"10.1016\/j.soc.2024.02.002_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s11605-014-2488-2","article-title":"A\u00a0Systematic Review of the Predictive Value of 18 FDG-PET in Esophageal and Esophagogastric Junction Cancer After Neoadjuvant Chemoradiation on the Survival Outcome Stratification","author":"Schollaert","year":"2014","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.soc.2024.02.002_bib74","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2363041042","article-title":"Esophageal cancer: CT, endoscopie US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review","volume":"236","author":"Westerterp","year":"2005","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.soc.2024.02.002_bib75","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1007\/s00330-016-4227-4","article-title":"Restaging oesophageal cancer after neoadjuvant therapy with 18F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery","volume":"26","author":"Findlay","year":"2016","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.soc.2024.02.002_bib76","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1245\/s10434-016-5754-6","article-title":"Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer","volume":"24","author":"Gabriel","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.soc.2024.02.002_bib77","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/cncr.30028","article-title":"Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma","volume":"122","author":"Ku","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.soc.2024.02.002_bib78","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-021-02313-3","article-title":"The value of restaging CT following neoadjuvant chemotherapy for resectable gastric cancer. A population-based study","volume":"19","author":"Sand\u00f8","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"SUPPL. 3","key":"10.1016\/j.soc.2024.02.002_bib79","article-title":"Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: Cohort evaluation within a randomized phase II study","volume":"21","author":"Yoshikawa","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2024.02.002_bib80","doi-asserted-by":"crossref","DOI":"10.1177\/2050640616684697","article-title":"Endoscopic ultrasound in gastric cancer staging before and after neoadjuvant chemotherapy. A comparison with PET-CT in a clinical series","volume":"5","author":"Redondo-Cerezo","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.soc.2024.02.002_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110843","article-title":"Prognostic value of [18F]FDG PET\/CT on treatment response and progression-free survival of gastroesophageal cancer patients undergoing perioperative FLOT chemotherapy","volume":"163","author":"Mirshahvalad","year":"2023","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.soc.2024.02.002_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/jso.25094","article-title":"Repeat staging laparoscopy for gastric cancer after preoperative therapy","volume":"118","author":"Thiels","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib83","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-012-2598-6","article-title":"Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy","volume":"20","author":"Cardona","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.02.002_bib84","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/curroncol29030120","article-title":"Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer","volume":"29","author":"Paschold","year":"2022","journal-title":"Curr Oncol"},{"issue":"24","key":"10.1016\/j.soc.2024.02.002_bib85","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1158\/1078-0432.CCR-18-1128","article-title":"Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction and Gastric Adenocarcinoma HHS Public Access","volume":"24","author":"Kato","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.soc.2024.02.002_bib86","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(20)31099-0","article-title":"Cytosponge-trefoil factor 3 versus usual care to identify Barrett\u2019s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial","volume":"396","author":"Fitzgerald","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00667-7","article-title":"Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett\u2019s oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot","volume":"23","author":"Pilonis","year":"2022","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.02.002_bib88","first-page":"164","article-title":"WATS 3D versus forceps biopsy in screening for Barrett\u2019s esophagus: experience in community endoscopy centers","volume":"34","author":"Hussein Agha","year":"2021","journal-title":"Ann Gastroenterol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T22:39:15Z","timestamp":1716417555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320724000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1055320724000140"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2024.02.002","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Diagnostic, Staging, and Restaging Evaluation of Esophageal and Gastric Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}